Eli Lilly and Company logo

Associate Director - External Innovation S&E Diabetes & Obesity

Eli Lilly and Company
Remote friendly (Indiana, United States)
United States
$145,500 - $213,400 USD yearly
Clinical Research and Development

Role Summary

Associate Director, External Innovation Diabetes & Obesity. Develop and implement External Innovation and Search & Evaluation strategy to secure pipeline impact across Diabetes & Obesity, supporting identification and evaluation of new opportunities and managing partner interactions from initial sanctioning through deal closure.

Responsibilities

  • Identify and map new innovative opportunities with bold understanding of disease biology.
  • Rigorously assess programs from biotech, small and large pharma for potential in-licensing/partnering opportunities assigned for review by leadership or identified proactively.
  • Manage all stages of partner interactions and evaluations, including initial contact, securing internal interest, meeting execution, coordinating internal debriefs, and supporting CMR Search & Evaluation leadership as needed.
  • Ensure prompt evaluation by functional experts (Biology, Chemistry, CMC, ADME, TOX, PK, legal, etc.) for opportunity evaluation and pre-diligence and provide partners with essential feedback/guidance.
  • Identify gaps and key issues and appropriate expertise to enable resolution.
  • Collaborate with internal scientific teams to identify, design, and implement the scientific experiments necessary to validate external opportunities.
  • Support consolidation of scientific feedback leading to internal recommendations and provision of partner responses.
  • Maintain awareness of external competitive landscapes for key target areas and assets by actively monitoring all relevant external preclinical- and clinical-stage assets within therapeutic areas.
  • Engage in scientific conferences as directed by CMR Search & Evaluation leadership to scout for new assets and technologies in line with R&D priorities.
  • Provide regular updates at the EI deals review sessions.

Qualifications

  • Required: PhD in Life Sciences related field, with track record in pre-clinical research and deep understanding of R&D processes and new modalities in the Diabetes & Obesity area.
  • Required: Minimum of 1-5 years of experience in the pharmaceutical industry.
  • Required: Strong scientific pedigree as evidenced by publications and presentations.
  • Required: Minimum of 1-2 years of experience in external research collaborations and S&E.
  • Preferred: Proven ability to work independently as well as in highly integrated cross-functional teams.
  • Preferred: Strong interpersonal and communication skills and the ability to represent Lilly in a highly professional manner.
  • Preferred: Track record of participation in scientific conferences in the cardiometabolic/WHS area and partnering conferences.
  • Preferred: Demonstrated track record in managing complex partnerships.

Education

  • PhD in Life Sciences related field

Additional Requirements

  • 25% travel anticipated
  • Remote location to be determined